FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/091728 [Registered on: 25/07/2025] Trial Registered Prospectively
Last Modified On: 24/07/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   This study looks at whether adding salicylic acid to anti fungal cream work better for treating ring worm than using anti fungal cream alone 
Scientific Title of Study   A COMPARATIVE STUDY TO EVALUATE THE EFFICACY OF 30% SALICYLIC ACID PEEL WITH TOPICAL LULICONAZOLE 1% CREAM VERSUS TOPICAL LULICONAZOLE 1% CREAM ALONE FOR THE TREATMENT OF CHRONIC TINEA CORPORIS. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
Nil  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Fathima Beevi 
Designation  Post graduate 
Affiliation  Bangalore medical college and research institute  
Address  Room no 208, department of dermatology, Victoria hospital,KR road, fort, Kalasipalya, Bangalore, Karnataka

Bangalore
KARNATAKA
560002
India 
Phone  9562662192  
Fax    
Email  fathimabeevi103@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Shilpa k 
Designation  Head of the department  
Affiliation  Bangalore medical college and research institute  
Address  Room no 208, department of dermatology, Victoria hospital, KR road, fort, Kalasipalya, Bangalore, Karnataka

Bangalore
KARNATAKA
560002
India 
Phone    
Fax    
Email  shilpakvinod1980@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Fathima Beevi 
Designation  Post graduate 
Affiliation  Bangalore medical college and research institute  
Address  Room no 208, department of dermatology, Victoria hospital, KR road, fort, Kalasipalya, Bangalore, Karnataka

Bangalore
KARNATAKA
560002
India 
Phone  9562662192  
Fax    
Email  fathimabeevi103@gmail.com  
 
Source of Monetary or Material Support  
Dr FATHIMA BEEVI POSTGRADUATE, DEPARTMENT OF DERMATOLOGY, VICTORIA HOSPITAL, ROOM NO 208, kr road forte, Karnataka ,India, PIN code : 560002 
 
Primary Sponsor  
Name  Dr Fathima beevi 
Address  BANGALORE MEDICAL COLLEGE AND RESEARCH INSTITUTE, FORT, KR ROAD, KALASIPALYA, BENGALURU KARNATAKA, PIN CODE- 560002 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Fathima Beevi  Victoria hospital   Room no 208, Department of dermatology, Victoria hospital,KR road, fort, Kalasipalya, Bangalore, Karnataka, PIN code - 560002
Bangalore
KARNATAKA 
09562662192

fathimabeevi103@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethics committee of BMCRI  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L088||Other specified local infections of the skin and subcutaneous tissue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Luliconazole 1% cream   Applied twice daily by the participant  
Intervention  Salicylic acid peel 30% plus luliconazole 1% cream  Salicylic acid peel 30% applied once weekly by the investigator plus luliconazole 1% cream twice daily applied by the participant 
 
Inclusion Criteria  
Age From  19.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients willing to give consent
Age group between 19-60 years
Chronic tinea corporis (more than 6 months)
KOH positive
 
 
ExclusionCriteria 
Details  Patients not willing to give informed consent.
Patients less than 18 years of age.
Pregnancy and lactation.
Patients with KOH mount negative.
Patients with more than 10% body surface area involvement.
Tinea faciei
Tinea cruris
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement in pruritis, erythema and scaling
KOH mount negative.
 
Baseline, 3 weeks, 6 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   10/08/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The financial burden of treating superficial dermatophytoses particularly in cases of extensive disease is often substantial and frequently incurred out-of-pocket by patients at all stages of treatment. The widespread use of ineffective and sometimes hazardous fixed drug combinations has contributed to the near-epidemic prevalence of superficial fungal infections. This in turn has led to chronic and treatment-resistant tinea infections. The present study aims to evaluate the efficacy of 30% salicylic acid in the management of tinea infection and its impact on duration of treatment.

 
Close